DK0679393T3 - Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol - Google Patents

Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol

Info

Publication number
DK0679393T3
DK0679393T3 DK95105766T DK95105766T DK0679393T3 DK 0679393 T3 DK0679393 T3 DK 0679393T3 DK 95105766 T DK95105766 T DK 95105766T DK 95105766 T DK95105766 T DK 95105766T DK 0679393 T3 DK0679393 T3 DK 0679393T3
Authority
DK
Denmark
Prior art keywords
treatment
pharmaceutical composition
xanthohumol
osteoporosis
osteoporosis containing
Prior art date
Application number
DK95105766T
Other languages
Danish (da)
English (en)
Inventor
Hiroyasu Tobe
Kazuyuki Kitamura
Osamu Komiyama
Original Assignee
Hoechst Marion Roussel Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Ltd filed Critical Hoechst Marion Roussel Ltd
Application granted granted Critical
Publication of DK0679393T3 publication Critical patent/DK0679393T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30Extraction of the material
    • A61K2236/33Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50Methods involving additional extraction steps
    • A61K2236/51Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK95105766T 1994-04-21 1995-04-18 Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol DK0679393T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6082852A JPH07285856A (ja) 1994-04-21 1994-04-21 骨粗鬆症治療剤

Publications (1)

Publication Number Publication Date
DK0679393T3 true DK0679393T3 (da) 1998-09-14

Family

ID=13785904

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95105766T DK0679393T3 (da) 1994-04-21 1995-04-18 Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol

Country Status (14)

Country Link
US (1) US5679716A (hu)
EP (1) EP0679393B1 (hu)
JP (1) JPH07285856A (hu)
KR (1) KR100350564B1 (hu)
AT (1) ATE162073T1 (hu)
AU (1) AU695696B2 (hu)
CA (1) CA2147419A1 (hu)
DE (1) DE69501419T2 (hu)
DK (1) DK0679393T3 (hu)
ES (1) ES2116642T3 (hu)
FI (1) FI951856A (hu)
HU (1) HUT71603A (hu)
NO (1) NO951498L (hu)
TW (1) TW284687B (hu)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008208A (en) * 1995-10-23 1999-12-28 Osteoscreen, Inc. Compositions and methods for treating bone deficit conditions
US6241762B1 (en) 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
DE19939350B4 (de) * 1999-08-19 2005-04-07 Plantextrakt Gmbh & Co. Kg Hopfenextrakt und Verfahren zu dessen Herstellung
US7268160B2 (en) * 2000-01-27 2007-09-11 Takara Bio, Inc. Remedies
KR100842693B1 (ko) * 2000-04-10 2008-07-01 다카라 바이오 가부시키가이샤 치료제
US6352726B1 (en) * 2001-01-09 2002-03-05 S. S. Steiner, Inc. Method of killing protozoa
US20040156950A1 (en) * 2001-04-05 2004-08-12 Green Martin Richard Use of hop components in foods
WO2003090555A1 (en) * 2002-04-24 2003-11-06 Unilever N.V. Use of hop components in foods
FR2823672B1 (fr) * 2001-04-23 2004-03-12 Berkem Sa Extraits de houblon et leur utilisation dans la preparation d'un medicament ayant des proprietes oestrogenes
KR100993113B1 (ko) * 2002-02-14 2010-11-08 기린 홀딩스 가부시키가이샤 지질대사 개선용 조성물 및 식품
DE10240065B4 (de) * 2002-08-30 2004-10-28 Hallertauer Hopfenveredlungsgesellschaft M.B.H. Verfahren zur Gewinnung von in Hopfen enthaltenem Xanthohumol und damit erhältlicher Xanthohumol-reicher Hopfenextrakt
DE50302729D1 (de) * 2002-12-18 2006-05-11 Doehler Gmbh Xanthohumol-haltiges Getränk
DE602004016486D1 (de) * 2003-04-08 2008-10-23 Kirin Brewery Zusammensetzung zur hemmung oder prävention der verringerung der knochendichte
DE102004063125B4 (de) * 2004-12-22 2007-03-15 Ta-Xan-Ag Natürlicher Xanthohumol-haltiger Extrakt sowie das Verfahren zu dessen Herstellung und daraus hergestellte Getränke
JP2009502973A (ja) * 2005-07-29 2009-01-29 バイオアクティブズ,インコーポレイティド プレニルフラボノイド製剤
DE102006062264A1 (de) * 2006-12-22 2008-06-26 Joh. Barth & Sohn Gmbh & Co. Kg Verwendung von Xanthohumol zur Vorbeugung und/oder Bekämpfung von Lebererkrankungen
EP2392325A1 (en) 2010-06-04 2011-12-07 Universitätsklinikum Münster Compounds for the prevention and/or treatment of osteoarthrosis
KR101323150B1 (ko) * 2011-04-25 2013-10-30 충남대학교산학협력단 잔토휴몰을 함유하는 골다공증 예방 및 치료용 조성물
CN103371989A (zh) * 2012-04-24 2013-10-30 华东师范大学 黄腐酚在制备抑制破骨细胞分化和蚀骨功能的预防和/或治疗药物中的应用
EP2877167B1 (en) 2012-07-26 2020-07-15 Arcaini, Antonio Uses of compositions containing a roasted extract and xanthohumol
JP6009498B2 (ja) * 2014-06-24 2016-10-19 国立大学法人京都大学 アルツハイマー病予防薬
JP2018519342A (ja) 2015-07-02 2018-07-19 フラクサン ゲーエムベーハー ウント コー. カーゲー ホップに基づく物質およびその物質の使用
CN105477686B (zh) * 2015-11-30 2019-02-15 长春工业大学 一种包覆黄腐酚的纳米纤维膜

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3794744A (en) * 1972-05-10 1974-02-26 White Tomkins Ltd Purification of hop extracts
US4065574A (en) * 1975-08-29 1977-12-27 The Upjohn Company New method for controlling fungi using 4-chromone, 4-chromanone, 4-chromone oxime and 4-chromanone oxime compounds

Also Published As

Publication number Publication date
JPH07285856A (ja) 1995-10-31
CA2147419A1 (en) 1995-10-22
TW284687B (hu) 1996-09-01
HUT71603A (en) 1996-01-29
NO951498L (no) 1995-10-23
EP0679393A2 (en) 1995-11-02
US5679716A (en) 1997-10-21
HU9501121D0 (en) 1995-06-28
NO951498D0 (no) 1995-04-20
AU695696B2 (en) 1998-08-20
KR100350564B1 (ko) 2002-12-16
FI951856A0 (fi) 1995-04-19
KR950031060A (ko) 1995-12-18
DE69501419D1 (de) 1998-02-19
DE69501419T2 (de) 1998-06-25
ATE162073T1 (de) 1998-01-15
ES2116642T3 (es) 1998-07-16
EP0679393B1 (en) 1998-01-14
EP0679393A3 (en) 1995-11-15
FI951856A (fi) 1995-10-22
AU1653595A (en) 1995-10-19

Similar Documents

Publication Publication Date Title
DK0679393T3 (da) Pharmaceutisk præparat til behandling af osteoporose indeholdende xanthohumol
DE69732170D1 (de) Formulierung mit verzögerter Freisetzung enthaltend Kollagen und Glykosaminoglykan
SE9901272D0 (sv) New improved formulation
DE69736441D1 (de) Pharmazeutische zusammensetzung zur behandlung von neurologischen und neuropsychiatrischen erkrankungen
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
HUP0000558A3 (en) Use of active d vitamin analogues for producing pharmaceutical composition for the treatment of prostatic diseases
PT750618E (pt) Derivados de oxazolidinona e composicoes farmaceuticas que os contem
BR9708114A (pt) Análogos xantona para o tratamento de doenças infecciosas.
ID18079A (id) Komposisi farmasi yang mengandung bahan pemercepat osteogenesis
NO994395L (no) Stabilt, fast preparat som inneholder vitamin D3 og trikalsiumfosfat
DE69314586D1 (de) Arzneimittelzusammensetzung enthaltend TCF-II
ATE231728T1 (de) Pharmazeutische zusammensetzung enthaltend interferon-gamma stimulatoren
DK0655251T3 (da) Farmaceutisk præparat til forebyggelse eller behandling af knoglebrud
EP0618812A4 (en) USE OF PROTEASE NEXIN-I AS ANTI-INFLAMMATORY.
DE59101818D1 (de) Arzneimittelzubereitung, enthaltend Stigmasta-4-en-3-on sowie deren Verwendung.
ATE333287T1 (de) Prophylaxe und behandlung von autoimmunen entmyelinisierungserkrankungen durch fas- antagonisten
DE69915852D1 (de) Lhrh-analoga zur behandlung der osteoporose
UA30143C2 (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
ATE329613T1 (de) Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas
IT1304852B1 (it) Miscela di piante medicinali per la prevenzione e la cura delleemorroidi.